Sanjivani Parenteral shares closed at 254.40 on February 19, 2025 (BSE) and has given -11.03% returns over the last 6 months and 53.72% over last 12 months. Earnings per share (EPS) has decreased to Rs. 1.62 in December 2024 from Rs.1.65 in December 2023. EBITDA stands at Rs. 2.86 crore in December 2025 up 28.83% from Rs 2.22 crore in 2023, according to the company’s quarterly report. The company’s net profit for the same period is Rs 1.90 crore, up 14.97% from 1.65 crore, the company said in a statement. The firm’s net sales for the quarter was Rs. 17.35 crore up 15.95% from. Rs. 14.96 crore, it said in the statement. It also said that the net profit from operations was higher than the net loss for the period due to higher sales and lower expenses.
